Skip Navigation

Cardiovascular Research 1999 44(3):568-578; doi:10.1016/S0008-6363(99)00258-8
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ulens, C.
Right arrow Articles by Tytgat, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ulens, C.
Right arrow Articles by Tytgat, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Norpropoxyphene-induced cardiotoxicity is associated with changes in ion-selectivity and gating of HERG currents

Chris Ulens, Paul Daenens and Jan Tytgat*

Laboratory of Toxicology, Faculty of Pharmaceutical Sciences, University of Leuven, Van Evenstraat 4, B-3000 Leuven, Belgium

* Corresponding author. Tel.: +32-16-32-3403; fax: +32-16-32-3405 jan.tytgat{at}farm.kuleuven.ac.be

Objective: Norpropoxyphene (NP) is a major metabolite of propoxyphene (P), a relatively weak µ-opioid receptor agonist. Toxic blood concentrations ranging from 3 to 180 µmol/l have been reported and the accumulation of NP in cardiac tissue leads to naloxone-insensitive cardiotoxicity. Since several lines of evidence suggest that not only block of INa but also IK block may contribute to the non-opioid cardiotoxic effects of P and NP, we investigated the effects of P and NP on HERG channels. HERG presumably encodes IKr, the rapidly-activating delayed rectifier K+ current, which is known to have an important role in initiating repolarization of action potentials in cardiac myocytes. Methods: Using the 2-microelectrode voltage clamp technique we investigated the interaction of P and NP with HERG channels, expressed in Xenopus oocytes. Results: Our experiments show that low drug concentrations (5 µmol/l) facilitate HERG currents, while higher drug concentrations block HERG currents (IC50-values of approx. 40 µmol/l) and dramatically shift the reversal potential to a more positive value because of a 30-fold increased Na+-permeability. P and NP also alter gating of HERG channels by slowing down channel activation and accelerating channel deactivation kinetics. The mutant S631C nullifies the effect of P and NP on the channel's K+-selectivity. Conclusion: P and NP show a complex and unique drug-channel interaction, which includes altering ion-selectivity and gating. Site-directed mutagenesis suggests that an interaction with S631 contributes to the drug-induced disruption of K+-selectivity. No specific role of the minK subunit in the HERG block mechanism could be determined.

KEYWORDS Gene expression; Ion channel, K-channel; Long QT syndrome; Gene expression; QT-dispersion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.